Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
DNA Ginkgo Bioworks Holdings, Inc.
For as long as anyone can remember, residents in Gaziantep have been harvesting wild pistachios to make a unique, nutty brew that doubles as a home remedy. Massimo Bottura is one of the world's best ...
Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Copyright © 2025 BBC. The BBC is not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback